COST-EFFECTIVENESS ANALYSIS OF DONEPEZIL AND RIVASTIGMINE FOR MILD TO MODERATE ALZHEIMER'S DISEASE IN TAIWAN

被引：1
|
作者：
Chen, T. S. [1 ]
Lang, H. C. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.493
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [31] Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease
    Waldemar, Gunhild
    Gauthier, Serge
    Jones, Roy
    Wilkinson, David
    Cummingss, Jeffrey
    Lopez, Oscar
    Zhang, Richard
    Xu, Yikang
    Sun, Yijun
    Knox, Sean
    Richardson, Sharon
    Mackell, Joan
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (02) : 150 - 157
  • [32] Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma, JC
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 414 - 415
  • [33] COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY
    Toumi, M.
    Lamure, M.
    Grishchenko, M.
    Cochran, J.
    Rive, B.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A370 - A370
  • [34] Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease
    Dartigues, JF
    Goulley, F
    Bourdeix, I
    Péré, JJ
    Barberger-Gateau, P
    [J]. REVUE NEUROLOGIQUE, 2002, 158 (8-9) : 807 - 812
  • [35] Results of an open clinical trial of rivastigmine in mild and moderate Alzheimer's disease
    Dennler, HJ
    Retz, W
    Rösler, M
    [J]. PSYCHOPHARMAKOTHERAPIE, 2001, 8 (03): : 111 - 117
  • [36] The safety and efficacy of Rivastigmine plus memantine versus Rivastigmine monotherapy in mild to moderate Alzheimer's disease
    Figiel, GS
    Figiel, S
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S186 - S187
  • [37] Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease
    Tanaka, M
    Namiki, C
    Thuy, DHD
    Yoshida, H
    Kawasaki, K
    Hashikawa, K
    Fukuyama, H
    Kita, T
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 225 (1-2) : 135 - 141
  • [38] No effect of donepezil on striatal dopamine release in mild to moderate Alzheimer's disease
    Reeves, S.
    Brown, R.
    Matthews, D.
    Howard, R.
    Grasby, P.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01): : 119 - 121
  • [39] Management of mild to moderate Alzheimer disease - Defining the role of rivastigmine
    Plosker, GL
    Keating, GM
    [J]. DISEASE MANAGEMENT & HEALTH OUTCOMES, 2004, 12 (01) : 55 - 72
  • [40] Donepezil for the treatment of mild to moderate Alzheimer's disease in France: The economic implications
    Fagnani, F
    Lafuma, A
    Pechevis, M
    Rigaud, AS
    Traykov, L
    Seux, ML
    Forette, F
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 5 - 13
12345